Bioscience - Lost in Translation?

Richard Bergstrm, Director, European Federation of Pharmaceutical Industry and Associations, Belgium Advance Praise: It is not easy to keep up with the rapid pace of biomedical innovation nor changes in society and markets. This book captures exactly where we are right now: an unprecedented wave of innovation that arrives in health systems that are not prepared. And neither is the business model of the pharmaceutical industry.

Professor Jeremy Farrar, Executive Director, The Wellcome Trust, UK Advance Praise: This is a timely and provocative analysis. It is crucially important that researchers, clinicians, industry, and regulators adapt effectively to the new era of stratified medicine. This book is a welcome contribution to the debate.

Dr Barbara Lopez Kunz, Global Chief Executive, Drug Information Association, Switzerland Advance Praise: Richard Barker presents a provocative and thoughtful review of the health care ecosystem, demonstrating time and again that communication and collaboration across the stakeholder community are essential to realizing patient benefits from biomedical innovation.

Professor Sir John Tooke, co-Chair of the Centre for the Advancement of Sustainable Medical Innovation, UK, former Vice-Provost of University College London Advance Praise: Richard Barker, drawing on a quarter of a century of deep practical involvement in the topic, has written an invaluable synthesis of the factors that account for the disappointing rate of translation of science into affordable treatments to address unmet clinical need. Crucial will be forging of transparent productive relationships between academia, industry and an enlightened regulatory system. Essential reading for all those interested in making the medical innovation process faster, more productive and sustainable.

Dr Michael Friedman, Emeritus Chief Executive, City of Hope Cancer Center, Duarte, CA, USA and board member of life science companies Advance Praise: Concisely frames the rich, dynamic environment for biologic/medical science with all the opportunities and challenges and offers orderly, thoughtful, practical approaches and solutions to facilitate and optimize medical innovation science. This book is suitable for both the knowledgeable scientific and the interested lay communities.

Mike Casey, board member and former Chief Executive of US biotech companies and former senior executive at Johnson & Johnson Advance Praise: This book provides an overview and in-depth analysis of medical science, drug development, etc., along with recommendations that are impressive. Amazing to say the least.

Stephen P. Spielberg, MD, PhD, former Dean, Dartmouth Medical School, Hannover, NH, USA, former Deputy Commissioner, US FDA, USA, and Editor-in-Chief, Therapeutic Innovation and Regulatory Science Advance Praise: This is an important and timely book. Richard Barker comprehensively reviews current progress, but perhaps more importantly points out e...

Professor Richard Barker has been Director of CASMI since its creation and was instrumental in its inception and launch. He is a strategic advisor, speaker and author on healthcare and life sciences. Richard has spent most of his career in healthcare, as a leader of organisations, as a board member and as a consultant. His leadership roles have spanned therapeutics, diagnostics and informatics both in the United States and in Europe. He was recently voted as one of the top 50 most influential people in UK healthcare and he sits on several healthcare and life sciences advisory boards on both sides of the Atlantic. His passions include securing a sustainable future for healthcare and redesigning how new medical technology is brought into practice. He now lives in London but is a frequent visitor to the US, where he spent 11 years working in Boston, New Haven, New York and San Francisco.

INDEX